Velarion Records
Free. Unsubscribe any time.

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

ALNYLAM PHARMACEUTICALS, INC. filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 286 transactions and 297,432 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in ALNYLAM PHARMACEUTICALS, INC. 286

Adoption dates in ALNYLAM PHARMACEUTICALS, INC. 14

Results prints in ALNYLAM PHARMACEUTICALS, INC. 7

Trades before a print in ALNYLAM PHARMACEUTICALS, INC. 21

Interval to ALNYLAM PHARMACEUTICALS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates ALNYLAM PHARMACEUTICALS, INC. states

Filing text: “10b5-1(c) trading plan adopted by the Reporting Person on December 16, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.